Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Abstract Background Serotonin syndrome is a rare but potentially severe disease, which is caused by hyperstimulation of serotonin receptors in the central nervous system. Several antidepressants exert their effect by modulating intrasynaptic serotonin concentration and anesthetics may affect the met...
Main Authors: | Junko Takata, Tomoko Arashi, Ayako Abe, Shoko Arai, Naoko Haruyama |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-08-01
|
Series: | JA Clinical Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40981-019-0275-5 |
Similar Items
-
The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
by: Dena Firouzabadi, et al.
Published: (2022-11-01) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
by: Zhong Z, et al.
Published: (2017-11-01) -
A study to understand the pattern of hyponatremia in patients using selective serotonin reuptake inhibitors and serotonin dopamine antagonists
by: Love Kumar Tomar, et al.
Published: (2021-01-01) -
New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
by: David Fanelli, et al.
Published: (2021-10-01)